Literature DB >> 30921705

Chemoresistance mechanisms of breast cancer and their countermeasures.

Xiwei Ji1, Yuan Lu2, Huifang Tian3, Xiangrui Meng4, Minji Wei2, William C Cho5.   

Abstract

Chemoresistance is one of the major challenges for the breast cancer treatment. Owing to its heterogeneous nature, the chemoresistance mechanisms of breast cancer are complicated, and not been fully elucidated. The existing treatments fall short of offering adequate solution to drug resistance, so more effective approaches are desperately needed to improve existing therapeutic regimens. To overcome this hurdle, a number of strategies are being investigated, such as novel agents or drug carriers and combination treatment. In addition, some new therapeutics including gene therapy and immunotherapy may be promising for dealing with the resistance. In this article, we review the mechanisms of chemoresistance in breast cancer. Furthermore, the potential therapeutic methods to overcome the resistance were discussed.
Copyright © 2019 The Authors. Published by Elsevier Masson SAS.. All rights reserved.

Entities:  

Keywords:  Anti-Resistance strategy; Breast cancer; Chemoresistance; Resistance mechanisms

Mesh:

Substances:

Year:  2019        PMID: 30921705     DOI: 10.1016/j.biopha.2019.108800

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  69 in total

1.  Hitting the brakes on autophagy for overcoming acquired resistance in triple negative breast cancer.

Authors:  Chiara Bellio; Josep Villanueva
Journal:  Ann Transl Med       Date:  2020-07

2.  Modulation of TLR/NF-κB/NLRP Signaling by Bioactive Phytocompounds: A Promising Strategy to Augment Cancer Chemotherapy and Immunotherapy.

Authors:  Sajad Fakhri; Seyed Zachariah Moradi; Akram Yarmohammadi; Fatemeh Narimani; Carly E Wallace; Anupam Bishayee
Journal:  Front Oncol       Date:  2022-03-01       Impact factor: 6.244

3.  SIRT7 interacts with TEK (TIE2) to promote adriamycin induced metastasis in breast cancer.

Authors:  Fan Yang; Ye Hu; Ling Shao; Jialang Zhuang; Qin Huo; Shengnan He; Siqi Chen; Juan Wang; Ni Xie
Journal:  Cell Oncol (Dordr)       Date:  2021-11-19       Impact factor: 6.730

Review 4.  Breast cancer: molecular mechanisms of underlying resistance and therapeutic approaches.

Authors:  Muhammad Tufail; Jia Cui; Changxin Wu
Journal:  Am J Cancer Res       Date:  2022-07-15       Impact factor: 5.942

Review 5.  Resveratrol in breast cancer treatment: from cellular effects to molecular mechanisms of action.

Authors:  Mitra Behroozaghdam; Maryam Dehghani; Amirhossein Zabolian; Davood Kamali; Salar Javanshir; Farzaneh Hasani Sadi; Mehrdad Hashemi; Teimour Tabari; Mohsen Rashidi; Sepideh Mirzaei; Atefeh Zarepour; Ali Zarrabi; Danielle De Greef; Anupam Bishayee
Journal:  Cell Mol Life Sci       Date:  2022-10-04       Impact factor: 9.207

6.  Toll-like receptor 2 promotes breast cancer progression and resistance to chemotherapy.

Authors:  Antonino Di Lorenzo; Elisabetta Bolli; Roberto Ruiu; Giuseppe Ferrauto; Enza Di Gregorio; Lidia Avalle; Aurora Savino; Pietro Poggio; Irene Fiore Merighi; Federica Riccardo; Mara Brancaccio; Elena Quaglino; Federica Cavallo; Laura Conti
Journal:  Oncoimmunology       Date:  2022-06-15       Impact factor: 7.723

Review 7.  Breast cancer stem cells: A review of their characteristics and the agents that affect them.

Authors:  Naing L Shan; Yoosub Shin; Ge Yang; Philip Furmanski; Nanjoo Suh
Journal:  Mol Carcinog       Date:  2021-01-11       Impact factor: 4.784

Review 8.  Chemoresistance and Metastasis in Breast Cancer Molecular Mechanisms and Novel Clinical Strategies.

Authors:  Jun Cao; Mengdi Zhang; Bin Wang; Long Zhang; Meiyu Fang; Fangfang Zhou
Journal:  Front Oncol       Date:  2021-07-01       Impact factor: 6.244

Review 9.  Current Knowledge of Long Non-Coding RNA HOTAIR in Breast Cancer Progression and Its Application.

Authors:  Yubo Shi; Qingyun Huang; Xinyu Kong; Ruichen Zhao; Xinyue Chen; Yujia Zhai; Lixia Xiong
Journal:  Life (Basel)       Date:  2021-05-26

Review 10.  Surface-functionalised hybrid nanoparticles for targeted treatment of cancer.

Authors:  Hasnat Tariq; Syed Ali Imran Bokhari
Journal:  IET Nanobiotechnol       Date:  2020-09       Impact factor: 1.847

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.